Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Neurologist ; 13(3): 150-3, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17495760

RESUMEN

BACKGROUND: As the population ages, the incidence of dementing illness is increasing. Accurate and timely diagnosis provides the best hope for instituting appropriate treatment and educating the patient and family members as to prognosis based upon likely etiology in a given patient. REVIEW SUMMARY: We present a case of an elderly patient referred to our tertiary-care center for further evaluation of a rapidly progressive dementia, whose definitive diagnosis was delayed by nonspecific MRI findings, presence of 14-3-3 protein in the CSF, and nonspecific cutaneous lesions. At brain biopsy, he was thought to have a diffusely infiltrating lymphoma, with distinctive immunohistochemical features. CONCLUSION: This case is notable in that it presents a patient with progressive dementia whose diagnosis of primary central nervous system lymphoma (PCNSL) was delayed because of the lymphoma's atypical diffusely infiltrating nature. Awareness of this unique presentation may hasten the time between clinical presentation, diagnosis, and subsequent treatment.


Asunto(s)
Neoplasias del Sistema Nervioso Central/complicaciones , Demencia/etiología , Linfoma/complicaciones , Anciano , Encéfalo/patología , Neoplasias del Sistema Nervioso Central/patología , Demencia/líquido cefalorraquídeo , Progresión de la Enfermedad , Humanos , Linfoma/patología , Imagen por Resonancia Magnética/métodos , Masculino
2.
J Am Med Dir Assoc ; 8(3): 150-7, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17349943

RESUMEN

Given the challenges and benefits of timely and accurate diagnosis of neurodegenerative disorders and the importance of appropriate subsequent treatments, physicians and patients alike desire tools that aid in diagnosing dementia as early and as precisely as possible. One of these tools may be functional brain imaging, specifically positron emission tomography (PET). Recent technological advancements, ongoing research studies, and approval for reimbursement by various insurance companies and Medicare, under certain circumstances, have led to an increased interest in the use of this tool in the evaluation of dementia. This article will review PET brain imaging in the initial assessment and diagnosis of dementia, including its place in current guidelines and role in diagnostic algorithms, its applicability in differentiating among various dementia syndromes and major psychiatric disorders, and some of the controversies surrounding its utility in general clinical practice.


Asunto(s)
Demencia/diagnóstico , Tomografía de Emisión de Positrones/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Demencia/economía , Demencia/epidemiología , Diagnóstico Diferencial , Costos de la Atención en Salud/estadística & datos numéricos , Humanos , Tomografía de Emisión de Positrones/economía , Tomografía de Emisión de Positrones/tendencias , Prevalencia , Tomografía Computarizada de Emisión de Fotón Único , Estados Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...